Free Trial

Burney Co. Cuts Stock Position in MetLife, Inc. (NYSE:MET)

MetLife logo with Finance background

Burney Co. lowered its holdings in shares of MetLife, Inc. (NYSE:MET - Free Report) by 9.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 68,168 shares of the financial services provider's stock after selling 7,267 shares during the quarter. Burney Co.'s holdings in MetLife were worth $5,473,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also bought and sold shares of MET. Brighton Jones LLC raised its stake in shares of MetLife by 9.0% in the fourth quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider's stock valued at $347,000 after acquiring an additional 351 shares during the period. EntryPoint Capital LLC purchased a new position in MetLife in the 4th quarter worth about $422,000. Modern Wealth Management LLC increased its stake in MetLife by 39.1% in the 4th quarter. Modern Wealth Management LLC now owns 7,560 shares of the financial services provider's stock worth $628,000 after buying an additional 2,124 shares during the period. TIAA Trust National Association increased its stake in MetLife by 8.7% in the 4th quarter. TIAA Trust National Association now owns 9,855 shares of the financial services provider's stock worth $807,000 after buying an additional 788 shares during the period. Finally, Meiji Yasuda Asset Management Co Ltd. increased its stake in MetLife by 140.5% in the 4th quarter. Meiji Yasuda Asset Management Co Ltd. now owns 52,522 shares of the financial services provider's stock worth $4,301,000 after buying an additional 30,682 shares during the period. Institutional investors own 94.99% of the company's stock.

MetLife Stock Up 1.0%

NYSE MET traded up $0.74 on Friday, hitting $78.53. The stock had a trading volume of 2,227,602 shares, compared to its average volume of 3,364,521. The business's fifty day moving average price is $78.72 and its 200 day moving average price is $79.72. The stock has a market cap of $52.72 billion, a price-to-earnings ratio of 12.77, a price-to-earnings-growth ratio of 0.64 and a beta of 0.85. The company has a debt-to-equity ratio of 0.55, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a 52-week low of $65.21 and a 52-week high of $89.05.

MetLife (NYSE:MET - Get Free Report) last released its earnings results on Wednesday, April 30th. The financial services provider reported $1.96 EPS for the quarter, missing analysts' consensus estimates of $2.00 by ($0.04). The company had revenue of $18.57 billion during the quarter, compared to analyst estimates of $18.06 billion. MetLife had a return on equity of 20.89% and a net margin of 6.08%. The firm's revenue for the quarter was up 15.6% on a year-over-year basis. During the same quarter last year, the business earned $1.83 earnings per share. Equities research analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife announced that its Board of Directors has approved a stock repurchase plan on Wednesday, April 30th that allows the company to buyback $3.00 billion in shares. This buyback authorization allows the financial services provider to purchase up to 5.9% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's management believes its stock is undervalued.

MetLife Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 9th. Shareholders of record on Tuesday, August 5th will be paid a dividend of $0.5675 per share. This represents a $2.27 annualized dividend and a yield of 2.89%. The ex-dividend date of this dividend is Tuesday, August 5th. MetLife's payout ratio is 36.91%.

Wall Street Analyst Weigh In

Several research firms recently commented on MET. UBS Group raised their price target on shares of MetLife from $94.00 to $98.00 and gave the stock a "buy" rating in a research note on Wednesday, April 2nd. Morgan Stanley cut their target price on shares of MetLife from $99.00 to $98.00 and set an "overweight" rating on the stock in a research report on Monday, July 14th. Keefe, Bruyette & Woods cut their target price on shares of MetLife from $95.00 to $94.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 9th. Barclays raised their target price on shares of MetLife from $88.00 to $94.00 and gave the company an "overweight" rating in a research report on Monday, July 7th. Finally, Piper Sandler raised their target price on shares of MetLife from $92.00 to $94.00 and gave the company an "overweight" rating in a research report on Wednesday, April 2nd. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $96.09.

Check Out Our Latest Report on MetLife

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Articles

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Should You Invest $1,000 in MetLife Right Now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines